APPLICATION
ANDA074280
TYPE
ANDA
ORIGINAL APPROVAL
1994-05-27
LATEST ACTION
1998-12-09
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued
Products
LORAZEPAMDiscontinued
LORAZEPAM 4MG/ML · INJECTABLE · INJECTION
LORAZEPAMDiscontinued
LORAZEPAM 2MG/ML · INJECTABLE · INJECTION
Approval history
1998-12-09Labeling · Supplement 4AP
1998-12-09Manufacturing (CMC) · Supplement 2AP
1998-02-24Labeling · Supplement 3AP
1994-05-27OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.